speb/financial-data huggingface dataset:
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — EBIT: 3687400000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — EBITDA: 11209800000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — EBITDA: 4791700000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 13900000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — End Cash Position: 995400000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 34100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 34100000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 392800000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 4845500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 4845500000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -393500000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -570500000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 803700000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Goodwill: 2463000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 2463000000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 2656200000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2656200000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 20580100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 20580100000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 64116000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 64116000000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Gross Profit: 29684500000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 9376200000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 0.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 0.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Interest Expense: 2065900000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 564000000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 2065900000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 564000000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Interest Income: 151700000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 151700000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -2092200000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 61500000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Inventory: 19365400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 19365400000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 71656400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 71656400000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -6817200000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 34200000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 34200000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Investmentsin Associatesat Cost: 1252100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 1252100000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Investmentsin Joint Venturesat Cost: 1046400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 1046400000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 101700000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 4871000000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 2005700000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 2005700000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 621900000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 621900000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 6455800000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 6455800000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 7077700000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 7077700000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 1788600000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -3157000000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 2298500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 2298500000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 1060900000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 1060900000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 40011300000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 40011300000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 1299600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 1299600000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Minority Interests: -200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 9000000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: -1053500000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 101700000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Net Debt: 25935400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 25935400000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -19200000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Net Income: 3583200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Net Income: 2336700000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 3583200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 2336700000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 3583400000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 2327700000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 3583200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 2336700000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 3583200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 2336700000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 4842900000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 3583400000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 2327700000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Net Interest Income: -1974600000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -564000000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -413900000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 1714000000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -1368400000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -1974600000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -564000000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: 1409900000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -413900000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Net PPE: 43159600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 43159600000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -5411300000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 3082400000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 42069400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 42069400000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 3476000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 3476000000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 318700000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 318700000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1060900000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1060900000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 1716100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 1716100000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 10639300000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 4791700000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Normalized Income: 3165708100.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 2336700000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 6016500000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Operating Income: 6251800000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Operating Income: 3101700000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Operating Revenue: 55078600000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 17203000000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 539252491.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 539252491.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 22100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 22100000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 347200000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 347200000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 260500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 260500000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 193200000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 193200000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 1947900000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 1328100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1328100000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 3476000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 3476000000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 585700000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 9295700000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 3393200000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Other Payable: 3557500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 3557500000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Other Properties: 1891400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 1891400000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 337600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 337600000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 505300000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 505300000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Other Special Charges: -570500000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Payables: 13145200000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Payables: 13145200000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 293400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 293400000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 2084400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 2084400000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Pretax Income: 4842900000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 3123400000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 533600000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: -1053500000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -6410000000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 7053400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 7053400000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 25394100000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 7826800000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 4300900000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1104300000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 35600000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 35600000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -3157000000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Research And Development: 553000000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 446700000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 446700000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 36264900000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 36264900000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 998700000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 1709500000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 2513200000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Share Issued: 539252491.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 539252491.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 3082400000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Special Income Charges: 570500000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 102300000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 44725600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 44725600000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 42069400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 42069400000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 153008100.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Tax Provision: 1298800000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 784700000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.27
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.25
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -1375400000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Total Assets: 93355700000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 93355700000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 51181400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 51181400000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Total Debt: 27637300000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 27637300000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 46025200000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 46025200000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Total Expenses: 48826800000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 14101300000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 47330500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 47330500000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 50032500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 50032500000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 11933300000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 11933300000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 60400000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 572000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 572000000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 570500000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 570500000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Work In Process: 7466500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 7466500000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Working Capital: 7926000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 7926000000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 6669300000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 15695700000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 539801325.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 3.02
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 6373500000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 1168400000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 1168400000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 539801325.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 3.02
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1630200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — EBIT: 2757200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — EBITDA: 3925600000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 9322200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 515000000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 515000000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 13400000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Net Income: 1630200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1630200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 1616800000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1630200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1630200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 1616800000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -515000000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -515000000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 3925600000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 1630200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Operating Income: 2652900000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 15695700000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 104300000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 3352900000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 2242200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 6373500000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1168400000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 631400000.00
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.28
LAURUSLABS.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 13042800000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 7241300000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 17782900000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 538886510.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 4.67
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 6945700000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 1206200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 1206200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 541204301.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 4.65
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2516600000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — EBIT: 3653500000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — EBITDA: 4859700000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 10837200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 387900000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 387900000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -2200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Net Income: 2516600000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 2516600000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 2518800000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2516600000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2516600000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 2518800000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -387900000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -387900000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 4859700000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 2516600000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Operating Income: 3595900000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 17782900000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 57600000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 3742700000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 3265600000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 6945700000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1206200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 734500000.00
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.22
LAURUSLABS.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 14187000000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — +Operating Expense: 26512700000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 7214600000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — +Total Revenue: 67212300000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 18115700000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 12520900000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 12520900000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 21549400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 21549400000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -25134500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -25134500000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 7647300000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 7647300000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1272400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1272400000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Amortization: 70000000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 539735793.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 539922631.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Basic EPS: 16.47
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 5.17
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 995400000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 17284500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 17284500000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -10699500000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 1209900000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1209900000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 1079700000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1079700000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 1126500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1126500000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1126500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1126500000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -863300000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 0.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 0.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 1126500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 1126500000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -4056000000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 248000000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 3126300000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Change In Payable: 2742800000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -1810300000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 250800000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 101200000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Common Stock: 1079700000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 1079700000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 53000600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 53000600000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 200000000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 7732800000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 7732800000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 27635900000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 7001000000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Current Assets: 48292100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 48292100000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 95000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 95000000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Current Debt: 17861500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 17861500000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 17956500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 17956500000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Current Deferred Taxes Liabilities: 542700000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Current Deferred Taxes Liabilities: 542700000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 36354300000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 36354300000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Depreciation: 4800500000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 4800500000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 4800500000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 1221000000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 4730500000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 1221000000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 540459589.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 539922631.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Diluted EPS: 16.45
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 5.17
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 8887900000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 2791400000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 3100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 3100000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — EBIT: 13429300000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — EBIT: 4018100000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — EBITDA: 18229800000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — EBITDA: 5239100000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 30000000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — End Cash Position: 1126600000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 210600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 210600000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -5247200000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 6393600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 6393600000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 5535500000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 74800000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 1018000000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Goodwill: 2463000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 2463000000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 2647000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2647000000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 22821800000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 22821800000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 73926700000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 73926700000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Gross Profit: 39576400000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 11114700000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Interest Expense: 1610500000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 404400000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 1610500000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 404400000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Interest Income: 65700000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 65700000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -1706900000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 65700000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Inventory: 23421600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 23421600000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 76975500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 76975500000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -10886600000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 210600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 210600000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Investmentsin Associatesat Cost: 1333600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Investmentsin Associatesat Cost: 1333600000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Investmentsin Joint Venturesat Cost: 1548500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Investmentsin Joint Venturesat Cost: 1548500000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 200000000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 2552600000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 2005700000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 2005700000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 1114900000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 1114900000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 6113400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 6113400000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 7228300000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 7228300000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 2552600000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -3268700000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 2882100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 2882100000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 44576600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 44576600000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 1313000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 1313000000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Minority Interests: -13500000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -29500000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -757200000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 200000000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Net Debt: 22848400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 22848400000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -258900000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Net Income: 8887900000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Net Income: 2791400000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 8887900000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 2791400000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 8901400000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 2820900000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 8887900000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2791400000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 8887900000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2791400000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 11818800000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 8901400000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 2820900000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Net Interest Income: -1603600000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -404400000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 436300000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -3165800000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -716100000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -1603600000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -404400000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: 423800000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Net PPE: 48792200000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 48792200000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -10631400000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -2449700000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 50353600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 50353600000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Revenue: 5394700000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 5394700000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 293800000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 293800000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1320900000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1320900000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 2248500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 2248500000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 18299800000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 5239100000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Normalized Income: 8940603000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 2791400000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 16235000000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Operating Income: 13063700000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Operating Income: 3900100000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Operating Revenue: 67212300000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 18115700000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 539856582.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 539856582.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 36200000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 36200000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 309100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 309100000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 249800000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 249800000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 184000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 184000000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 1582800000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 159500000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 118000000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 10927400000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 3635100000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Other Payable: 3451500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 3451500000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Other Properties: 2327100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 2327100000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 449900000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 449900000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Other Special Charges: 70000000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Payables: 15975500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Payables: 15975500000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 378900000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 378900000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 1698100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 1698100000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Pretax Income: 11818800000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 3613700000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 795400000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: -757200000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -10699500000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 8395200000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 8395200000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 27635900000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 7001000000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 4800500000.00
LAURUSLABS.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1221000000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 39200000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 39200000.00
LAURUSLABS.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -5718400000.00
LAURUSLABS.NS income_statement (annual, 2026-03-31) — Research And Development: 276600000.00
LAURUSLABS.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 10400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 10400000.00